Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype defined by lack of targetable estrogen receptor (ER), progesterone receptor (PR), and HER2 [1]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.